Provided by Tiger Trade Technology Pte. Ltd.

Valneva SE

5.06
+0.10002.02%
Post-market: 5.060.00000.00%16:10 EDT
Volume:6K
Turnover:32.00K
Market Cap:480.12M
PE:-2.77
High:5.15
Open:5.00
Low:4.99
Close:4.96
52wk High:12.25
52wk Low:4.75
Shares:94.89M
Float Shares:85.93M
Volume Ratio:0.78
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8266
EPS(LYR):-1.6084
ROE:-109.57%
ROA:-14.54%
PB:5.50
PE(LYR):-3.15

Loading ...

Top Premarket Decliners

MT Newswires Live
·
Mar 23

Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial

TIPRANKS
·
Mar 23

Pfizer: Co & Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 Valor Trial

THOMSON REUTERS
·
Mar 23

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Reuters
·
Mar 23

Guggenheim Reaffirms Their Buy Rating on Valneva (VALN)

TIPRANKS
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Valneva (VALN) and Protagonist Therapeutics (PTGX)

TIPRANKS
·
Mar 19

Goldman Sachs Reaffirms Their Hold Rating on Valneva (VALN)

TIPRANKS
·
Mar 19

Valneva Licenses C. Difficile Antigen Technology to Elaris

MT Newswires Live
·
Mar 18

Elaris FlexCo secures exclusive global license from Valneva

TIPRANKS
·
Mar 18

Valneva 2025 Loss Widens, Revenue Rises; Shares Down Pre-Bell

MT Newswires Live
·
Mar 18

Valneva Q4 EPS $(0.68) Misses $(0.21) Estimate, Sales $55.516M Miss $56.190M Estimate

Benzinga Earnings
·
Mar 18

Press Release: Valneva Reports Full Year 2025 Audited Consolidated Financial Results

Dow Jones
·
Mar 18

Valneva SE expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
Mar 16

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oxford BioMedica (OtherOXBDF), Valneva (VALN) and Supernus Pharmaceuticals (SUPN)

TIPRANKS
·
Feb 27

Valneva FY 2025 third-party product sales EUR 19.2 million -42.3%

Reuters
·
Feb 19

BUZZ-Valneva jumps on 'attractive' risk/reward profile ahead of vaccine's phase 3 results

Reuters
·
Feb 04

Valneva, Instituto Butantan Start Pilot Program for Chikungunya Vaccine in Brazil

MT Newswires Live
·
Feb 03